First published: Tue Apr 08 2025(Updated: )
<p>Use after free in Windows LDAP - Lightweight Directory Access Protocol allows an unauthorized attacker to execute code over a network.</p>
Credit: secure@microsoft.com
Affected Software | Affected Version | How to fix |
---|---|---|
Windows 11 | =22H2 | |
Windows 11 | =24H2 | |
Microsoft Windows Server 2022 | ||
Microsoft Windows Server 2025 | ||
Microsoft Windows Server | ||
Microsoft Windows Server | ||
Windows 10 | =1607 | |
Windows 10 | =1607 | |
Microsoft Windows Server | ||
Windows 10 | =21H2 | |
Microsoft Windows Server | ||
Windows 11 | =23H2 | |
Microsoft Windows Server 2016 | ||
Windows 10 | =22H2 | |
Windows 10 | =21H2 | |
Windows 10 | =22H2 | |
Microsoft Windows Server 2008 R2 | ||
Microsoft Windows Server 2025 | ||
Windows 10 | =21H2 | |
Windows 11 | =23H2 | |
Microsoft Windows Server 2016 | ||
Microsoft Windows Server 2022 23H2 | ||
Microsoft Windows Server | ||
Microsoft Windows Server | ||
Microsoft Windows Server 2008 R2 | ||
Windows 10 | =1809 | |
Microsoft Windows Server 2019 | ||
Microsoft Windows Server 2012 R2 | ||
Microsoft Windows Server 2012 R2 | ||
Windows 10 | =22H2 | |
Windows 11 | =22H2 | |
Microsoft Windows Server 2019 | ||
Windows 11 | =24H2 | |
Windows 10 | =1809 | |
Microsoft Windows Server 2022 | ||
Windows 10 | ||
Windows 10 |
Sign up to SecAlerts for real-time vulnerability data matched to your software, aggregated from hundreds of sources.
(Found alongside the following vulnerabilities)
CVE-2025-26663 is considered a critical vulnerability that can allow unauthorized code execution over a network.
To fix CVE-2025-26663, apply the recommended patches provided by Microsoft for your affected Windows version.
CVE-2025-26663 affects various versions including Windows 10, Windows 11, and multiple Windows Server editions.
The risks include potential unauthorized access, data breaches, and remote code execution capabilities for attackers.
Currently, the best practice is to apply the patch as soon as it is available; no specific workaround is recommended.